{"Name":"Adheron Therapeutics","perma":"adheron-therapeutics","BasicInfo":{"funded":"2003-01-01","isClosed":false,"closed":null,"short":"Adheron is a biotechnology company focused on leveraging pioneering technology that disrupts cell adhesion to treat a variety of diseases."},"FundingRounds":[{"funding_type":"convertible_note","series":null,"announcedDate":"2015-07-31","moneyRaised":1500000}],"Acquisitions":[],"AcquiredBy":{"price":580000000,"paymentType":null,"announcedDate":"2015-10-07","completedDate":"2015-10-07","acquisitionType":"Acquisition","acquirer":"Roche"},"IPO":null,"Investments":[],"Products":[],"ProductsPermas":[],"CurrentTeam":[{"title":"CEO","started":null,"ended":null,"firstName":null,"lastName":null}],"PastTeam":[]}
